Increasing the class of foundational medication for heart failure is associated with improved prognosis in hospitalized patients with heart failure with reduced or mildly reduced ejection fraction
27 August 2022 (12:15 - 12:45)
Organised by:
Abstract
Slides
About the speaker
Juntendo University Graduate School of Medicine, Tokyo (Japan)
4 More presentations in this session
Doctor M. Massot (Toulouse, FR)
Access the full session
The Event
ESC Congress 2022
27 August 2022
12:15 CET
